Hepatology Stocks List
|ARBI||D||Arbios Systems Inc New||0.00|
|HBRM||D||Herborium Group Inc||0.00|
|NVSEF||C||Novartis Ag Basl||0.00|
|DCTH||D||Delcath Systems Inc||0.00|
|RYMDF||F||Relay Medical Corp.||0.00|
|OCMMF||B||Oncimmune Holdings Plc||0.00|
View all Hepatology related ETFs...
|2021-05-05||HBRM||Crossed Above 200 DMA||Bullish|
|2021-05-05||HBRM||Narrow Range Bar||Range Contraction|
|2021-05-05||HBRM||Doji - Bullish?||Reversal|
|2021-05-05||HBRM||Lizard Bullish||Bullish Day Trade Setup|
|2021-05-05||HBRM||Bollinger Band Squeeze||Range Contraction|
|2021-05-05||RYMDF||Fell Below 200 DMA||Bearish|
Hepatology is the branch of medicine that incorporates the study of liver, gallbladder, biliary tree, and pancreas as well as management of their disorders. Although traditionally considered a sub-specialty of gastroenterology, rapid expansion has led in some countries to doctors specializing solely on this area, who are called hepatologists.
Diseases and complications related to viral hepatitis and alcohol are the main reason for seeking specialist advice. More than two billion people have been infected with hepatitis B virus at some point in their life, and approximately 350 million have become persistent carriers. Up to 80% of liver cancers can be attributed to either hepatitis B or hepatitis C virus. In terms of mortality, the former is second only to smoking among known agents causing cancer. With more widespread implementation of vaccination and strict screening before blood transfusion, lower infection rates are expected in the future. In many countries however, overall alcohol consumption is increasing, and consequently the number of people with cirrhosis and other related complications is commensurately increasing.